Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 11,601–11,625 of 27,380 studies, newest first · page 465 of 1096.

May 2020 25

  1. 2020-05-27

    Structures of α-synuclein filaments from multiple system atrophy

    ✓ Peer-reviewed Brain tissue and pathology Nature

    Key finding: Using two-dimensional class averaging, we show that α-synuclein filaments from the brains of individuals with MSA differ from those of individuals with DLB, which suggests that distinct conformers or strains characterize specific synucleinopathies. +1 more finding

  2. 2020-05-26

    Mitigating the Effects of a Pandemic: Facilitating Improved Nursing Home Care Delivery Through Technology

    ✓ Peer-reviewed Health systems and care delivery JMIR aging

    Key finding: Residents are experiencing social isolation, which can result in physical and behavioral health issues, particularly for persons with dementia.

  3. 2020-05-26

    Ageing without dementia: can stimulating psychosocial and lifestyle experiences make a difference?

    ✓ Peer-reviewed Risk factors The Lancet. Neurology

    Key finding: Evidence from observational studies is robust enough to suggest that stimulating psychosocial and lifestyle factors are protective against dementia.

  4. 2020-05-26

    Spread of pathological tau proteins through communicating neurons in human Alzheimer's disease

    ✓ Peer-reviewed Brain scans and imaging Nature communications

    Key finding: Tau is a hallmark pathology of Alzheimer's disease, and animal models have suggested that tau spreads from cell to cell through neuronal connections, facilitated by β-amyloid (Aβ). +2 more findings

  5. 2020-05-26
  6. 2020-05-26

    Effect of ApoE isoforms on mitochondria in Alzheimer disease

    ✓ Peer-reviewed Genetics Neurology

    Key finding: ApoE isoforms influence mitochondrial structure and function, which likely leads to alteration in oxidative stress, synapses, and cognitive function. +2 more findings

  7. 2020-05-26

    Plasma neurofilament light chain in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional and longitudinal cohort study

    ✓ Peer-reviewed Biomarkers The Lancet. Neurology

    Key finding: We enrolled a cohort of 1070 PSEN1 E280A mutation carriers and 1074 non-carriers with baseline assessments; of these participants, longitudinal measures (with a mean follow-up of 6 years) were available for 242 mutation carriers and 262 non-carriers.

  8. 2020-05-25

    APOE e4 Genotype Predicts Severe COVID-19 in the UK Biobank Community Cohort

    ✓ Peer-reviewed Clinical safety The Journals of Gerontology Series A

    Key finding: In older adults, we found that pre-existing dementia is a major risk factor (OR = 3.07, 95% CI: 1.71 to 5.50) for COVID-19 hospitalization in the UK Biobank (UKB). +2 more findings

  9. 2020-05-25

    Recent trends in mental illness and omega-3 fatty acids

    ✓ Peer-reviewed Prevention and risk Journal of neural transmission (Vienna, Austria : 1996)

    Key finding: Following a report by Hibbeln (Lancet 351:1213, 1998) published in The Lancet, which suggested that depression rates and fish consumption were inversely correlated, the relationships between a variety of nutritional/epidemiological treatments and neuropsychiatric disorders have received increased attention.

  10. 2020-05-25

    Microglia influence host defense, disease, and repair following murine coronavirus infection of the central nervous system

    ✓ Peer-reviewed TREM2 and immune genetics Glia

    Key finding: Treatment with PLX5622, an inhibitor of colony stimulating factor 1 receptor (CSF1R) that efficiently depletes microglia, prior to infection of the central nervous system (CNS) with the neurotropic JHM strain of mouse hepatitis virus (JHMV) resulted in increased mortality compared with control mice that correlated with impaired control of viral replication. +3 more findings

  11. 2020-05-22

    Impact of antidiabetic agents on dementia risk: A Bayesian network meta-analysis

    ✓ Peer-reviewed Drug development Metabolism: clinical and experimental

    Key finding: This analysis indicated that patients with type 2 diabetes under treatment with DPP-4 inhibitors presented with the lowest risk of dementia, followed by those treated with metformin and thiazolidinedione, while treatment with insulin was associated with the highest risk. +4 more findings

  12. 2020-05-22

    Prognostic value of ATN Alzheimer biomarkers: 60-month follow-up results from the Argentine Alzheimer's Disease Neuroimaging Initiative

    ✓ Peer-reviewed Tau biomarkers Alzheimer's & dementia (Amsterdam, Netherlands)

    Key finding: Twenty-three patients with mild cognitive impairment (MCI), 12 dementia of Alzheimer's type (DAT), and 14 normal controls were studied following the ADNI2 protocol. +3 more findings

  13. 2020-05-21

    Hippocampal overexpression of TREM2 ameliorates high fat diet induced cognitive impairment and modulates phenotypic polarization of the microglia

    ✓ Peer-reviewed TREM2 and immune genetics Genes & diseases

    Key finding: Rare variants of triggering receptor expressed on myeloid cells 2 (TREM2) increase the risk of developing AD, suggesting the involvement of TREM2 and innate immunity in AD development. +3 more findings

  14. 2020-05-21

    The late stage of Parkinson's -results of a large multinational study on motor and non-motor complications

    ✓ Peer-reviewed Digital health tools Parkinsonism & related disorders

    Key finding: These data suggest that current treatment of late stage parkinsonism in the community remains insufficiently effective to alleviate disabling symptoms in many patients. +2 more findings

  15. 2020-05-20

    Polygenic risk and pleiotropy in neurodegenerative diseases

    ✓ Peer-reviewed Genetics Neurobiology of disease

    Key finding: We conclude that the exploitation of pleiotropy may aid in the identification of novel genes and provide further insights in the disease mechanisms, and along with PRS analysis, may be advantageous for precision medicine.

  16. 2020-05-20

    A meta-analysis of gene expression data highlights synaptic dysfunction in the hippocampus of brains with Alzheimer's disease

    ✓ Peer-reviewed Disease mechanisms Scientific reports

    Key finding: We found that only the calcium signalling pathway enriched by 48 downregulated genes was consistent between all three studies. +1 more finding

  17. 2020-05-20

    Depression-an underrecognized target for prevention of dementia in Alzheimer's disease

    ✓ Peer-reviewed Prevention and risk Translational psychiatry

    Key finding: While several recent guidelines and multidomain intervention trials on prevention of cognitive decline address lifestyle factors and risk diseases, such as hypertension and diabetes, a special reference to the established risk factor of depression or depressive symptoms is systematically lacking. +4 more findings

  18. 2020-05-19

    Technology Literacy as a Barrier to Telehealth During COVID-19

    ✓ Peer-reviewed Cognitive tests and assessment Telemedicine Journal and e-Health

    Key finding: Prior work has shown that the video component significantly contributes to quality and satisfaction of the visit.3 In addition to the technology itself, patients need to know what to expect for their telehealth appointments. +1 more finding

  19. 2020-05-19

    Increased apolipoprotein E and decreased TNF-α in the cerebrospinal fluid of nondemented APOE-ε4 carriers

    ✓ Peer-reviewed Genetics Neuropsychopharmacology reports

    Key finding: CSF levels of apoE2, apoE3, and apoE4 were significantly higher (all nominal P < 10 × 10-5 , false discovery rate < 0.001) and those of tumor necrosis factor-α (TNF-α) were significantly lower (nominal P = 1.39 × 10-6 , false discovery rate < 0.001) in APOE-ε4 carriers than in noncarriers. +2 more findings

  20. 2020-05-19

    How to do things with (thousands of) words: Computational approaches to discourse analysis in Alzheimer's disease

    ✓ Peer-reviewed Digital health tools Cortex; a journal devoted to the study of the nervous system and behavior

    Key finding: The study of Alzheimer's disease (AD), and preclinical Mild Cognitive Impairment (MCI), suggests that changes in discourse (connected speech or writing) may be key to early detection of disease. +1 more finding

  21. 2020-05-19

    Association of Blood Pressure Lowering With Incident Dementia or Cognitive Impairment: A Systematic Review and Meta-analysis

    ✓ Peer-reviewed Prevention and risk JAMA

    Key finding: In this meta-analysis of randomized clinical trials, blood pressure lowering with antihypertensive agents compared with control was significantly associated with a lower risk of incident dementia or cognitive impairment. +3 more findings

  22. 2020-05-18

    Association of cerebrospinal fluid neurogranin levels with cognition and neurodegeneration in Alzheimer's disease

    ✓ Peer-reviewed Tau biomarkers Aging

    Key finding: To investigate whether the CSF Ng can be used for diagnosis, prognosis, and monitoring of AD, we examined 111 cognitively normal (CN) controls, 193 mild cognitive impairment (MCI) patients and 95 AD patients in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort. +3 more findings

  23. 2020-05-17

    [The cognitive-behavioural impact of hypertension]

    ✓ Peer-reviewed Risk factors Hipertension y riesgo vascular

    Key finding: Arterial hypertension is considered the main modifiable vascular risk factor that causes silent damage to brain vessels. +3 more findings

  24. 2020-05-17

    Epigenome signatures landscaped by histone H3K9me3 are associated with the synaptic dysfunction in Alzheimer's disease

    ✓ Peer-reviewed Disease mechanisms Aging cell

    Key finding: Biological network analysis further revealed H3K9me3-landscaped epigenomes to be mainly involved in synaptic transmission, neuronal differentiation, and cell motility. +1 more finding

  25. 2020-05-16

    Characteristics and Outcomes of Dementia Patients Who Receive Inpatient Palliative Care Consultation

    ✓ Peer-reviewed End-of-life care Journal of the American Geriatrics Society

    Key finding: Among 927 hospitalized patients with dementia, 17% received IPCC (N = 157). +4 more findings

Browse the library by subject, with the full score breakdown →